Strategic Expansion Tides Medical is actively expanding its wound care technology through partnerships with healthcare providers, evidenced by the Opelousas General collaboration on Aplicor 3D tissue regeneration, signaling growing adoption opportunities with hospital systems and wound care centers.

Growth Momentum With 50 to 200 employees and revenue between 50M and 100M, the company is recognized for rapid growth, including an Inc. 5000 ranking in 2025, indicating a track record of scaling that can be leveraged to pursue larger hospital networks and regional health systems.

Innovative Portfolio Recent launch of APLICOR 3D and emphasis on personalized, adipose-derived tissue grafts position Tides Medical at the forefront of advanced wound care technology, presenting cross-sell opportunities to add-on modules, services, and reimbursement support for existing customers.

Strategic Ecosystem Strong emphasis on end-to-end wound care lifecycle support from development to reimbursement creates upsell potential for hospitals and providers seeking integrated solutions, including training, implementation, and payer navigation services.

Recognition & Credibility Awarded Company of the Year by LABI and Lantern Awards recognition bolster credibility with health systems and regional purchasers, facilitating introductions and faster engagement with procurement teams in biotech and surgical markets.